Archived Announcements

Antifungal Drug Monitoring of Isavuconazole (Cresemba®)


Isavuconazole (trade name Cresemba®) is an antifungal drug that is FDA approved for the treatment of invasive aspergillosis and invasive mucormycosis. These life-threatening infections are caused by mold and fungi common to the environment, and occur in individuals with weakened immune systems or who have other complicating conditions, such as diabetes, asthma or lung disease.

Therapeutic drug monitoring (TDM) of isavuconazole is indicated to achieve the ideal balance between treatment efficacy and toxicity and assist physicians in optimizing patient outcomes.

2457SP Isavuconazole, Serum/Plasma

« Return to News Listing